Experiment 375300

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE

Compounds isolated

BRYOSTATIN 1

Alerts

A MIXTURE OF PURE COMPOUNDS WAS USED TO OBTAIN THE REPORTED EFFECT.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIP
OrganismEmpty organism
CitationMOHAMMAD,RM: VARTERASIAN,ML: ALMATCHY,VP: HANNOUDI,GN: PETTIT,GR: AL-KATIB,A:. (1998). SUCCESSFUL TREATMENT OF HUMAN CHRONIC LYMPHOCYTE LEUKEMIA XENOGRAFTS WITH COMBINATION BIOLOGICAL AGENTS AURISTATIN PE AND BRYOSTATIN 1.. 4(5)
Amount utilized
Compound isolated
DiseaseANIMALS WERE TREATED IN COMBINATION WITH DOLASTATIN 10.
Dose amount75.0 MCG
Number1
Qualitative resultWEAK ACTIVITY
AnimalMOUSE
Per unitKG
Dose expressionDOSE
GenderMALE